Anas H. Alzahrani: A Systematic Review of a Physician-Scientist Building Bridges Between Data and Decisions
2Local & International Collaboration Unit, KAU Faculty of Medicine
Abstract
Background: Modern research requires methodological rigor combined with clinical insight. This profile examines the career trajectory of a physician-scientist who has dedicated two decades to building infrastructure for evidence-based medicine.
Methods: Longitudinal analysis of training across four continents (North America, Europe, Middle East, and beyond), combined with systematic evaluation of research output and institutional impact.
Results: The subject demonstrates expertise in causal inference, real-world evidence, and health data science, with particular focus on propensity score methods, instrumental variables, and target trial emulation. Notable achievements include analysis of 75M+ patient records and establishment of international research collaborations.
Conclusions: Study design comes before statistics. Assumptions precede models. Methods are not buttons.
1. Introduction
Born in Dublin and raised in Jeddah, this researcher began coding at age five—a fact that would later prove foundational to a career spanning surgery, epidemiology, and health data science. The present work reviews the methodological contributions and career trajectory of a physician-scientist committed to translating complex data into actionable clinical insights.
The central hypothesis of this career has been simple but powerful: rigorous methodology, combined with clinical understanding, can transform how we generate and apply medical evidence.
2. Methods
2.1 Educational Pipeline
Training followed a multi-continental protocol: MBBS from King Abdulaziz University (Saudi Arabia), MPH in Epidemiologic & Biostatistical Methods from Johns Hopkins Bloomberg School of Public Health (USA), and PhD in Clinical Research from Icahn School of Medicine at Mount Sinai (USA).
2.2 Methodological Toolkit
Primary analytical approaches include:
- Propensity score methods (matching, weighting, stratification)
- Instrumental variable analysis
- Target trial emulation
- Survival analysis (Kaplan-Meier, competing risks)
- Hierarchical modeling and Bayesian methods
- Probabilistic data linkage at scale
2.3 Technical Infrastructure
Software competencies span Stata (20+ years), Python, R, SAS, and SQL, with experience in high-performance computing environments for processing datasets exceeding 75 million patient records.
3. Results
3.1 Career Timeline
3.2 Domain Expertise
| Domain | Competency Level | Key Applications |
|---|---|---|
| Causal Inference | Expert | IV, PSM, Target Trials |
| Biostatistics | Expert | Survival, Meta-analysis |
| Clinical Research | Expert | RCT Design, CER |
| Data Engineering | Advanced | Claims Data, HPC |
| AI/ML Healthcare | Advanced | CDSS, Guidelines |
3.3 Current Initiatives
Active projects include a 2.5M SAR grant for Clinical Decision Support Systems in antibiotic prescribing, the Automated Guideline Expansion Framework (AGEF), and development of living clinical guidelines platforms.
4. Discussion
"Study design comes before statistics. Assumptions precede models. Methods are not buttons."
This philosophy distinguishes the present work from purely technical approaches. The recognition that a perfect analysis cannot rescue a flawed study design has been central to all methodological contributions.
Current efforts focus on building institutional infrastructure: international collaborations with University of Arizona, Weill Cornell Medicine, and strategic partnerships across USA, UK, Germany, and China.
5. Conclusions
The evidence supports a career trajectory optimized for methodological impact. Future directions include expansion of AI-augmented research tools, continued development of living guidelines platforms, and training the next generation of rigorous clinical researchers.
Interested parties are encouraged to initiate collaboration through the corresponding author contact information provided above.
References
- Alzahrani AH et al. Choice of revascularization strategy for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2024.
- Alzahrani AH et al. Temporal Trend in Revascularization for Ischemic Cardiomyopathy. JAHA 2024;13:e032212.
- Alzahrani A et al. Endoglin haploinsufficiency and ECM regulation. J Cell Commun Signal 2018;12:379-388.
- Full publication list: orcid.org/0000-0002-1394-9157
Open for Collaboration
Interested in research partnerships, methodology consulting, or academic collaboration?
Contact the Author →